Fortress Biotech (NASDAQ:FBIO – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Monday. Several other research firms have also recently weighed in on FBIO. Alliance Global Partners initiated coverage on shares of Fortress Biotech in a research report […]